Reevaluating Obesity Diagnosis: Beyond BMI
Relying solely on the Body Mass Index (BMI) to diagnose obesity and assess its health implications may prove to be inadequate. This approach risks delaying timely medical attention for countless individuals whose mortality risk increases due to this condition. Recent international research published in a prominent scientific journal highlights the urgent need to reassess the criteria used to evaluate this chronic illness, which currently affects approximately one in seven adults globally.
Integrating Additional Measurements for Accurate Assessment
The study revisits a proposal from a renowned medical journal, suggesting that a more accurate diagnosis of obesity should not depend solely on BMI, which correlates weight with height. Instead, it advocates for the inclusion of additional metrics, such as waist circumference and waist-to-height ratio. Furthermore, it emphasises the necessity of evaluating whether excess body fat adversely impacts the normal functioning of organs.
This initiative also calls for a distinction between preclinical and clinical obesity. Preclinical obesity refers to a state where excess fat exists without any functional impairment in bodily systems, while clinical obesity is characterised by elevated fat levels that lead to organ dysfunction or hinder daily activities.
To test this model, researchers analysed data from over 844,100 adults across China, the United Kingdom, the United States, and Spain. The evaluation compared traditional BMI scores with those derived from measurements that included waist circumference and the waist-to-height ratio. Additionally, the study examined medical records to identify potential organ dysfunctions, differentiate between preclinical and clinical obesity, and establish a correlation between these classifications and mortality risk.
Unveiling the Underestimated Impact of Obesity
The findings revealed that the current BMI methodology overestimated obesity prevalence by 1.2 to 3.1% among participants. Conversely, it failed to recognise between 5.2 and 8.6% of individuals who, based on abdominal measurements, met the criteria for obesity diagnosis.
Francesco Rubino, a bariatric surgeon at King’s College London and co-author of the study, remarked that prior to this research, it was unclear whether the proposed framework by the medical journal would have clinical implications or effectively predict risks. Nonetheless, he underscored that the overall findings suggest “millions of individuals may be misdiagnosed based solely on BMI.”
Understanding Clinical and Preclinical Obesity
The study also reinforced the significance of differentiating between preclinical and clinical obesity. By applying the proposed classification, scientists found that clinical obesity accounted for 22.7 to 31.3% of identified cases. Moreover, the evaluation indicated that 70 to 90% of participants diagnosed with preclinical obesity did not experience significant complications over a ten-year period. This suggests that not all individuals with excess body fat suffer from organ damage or necessarily progress to a disease that impairs their functions.
Furthermore, the research indicated that mortality predictions based solely on BMI were inconsistent. In contrast, clinical obesity was associated with a 69% higher likelihood of death from any cause compared to the reference group, while those with preclinical obesity faced a 19% increase in mortality risk.
The Need for Broader Research and Application
Based on these findings, researchers concluded that “BMI alone misclassifies obesity in a significant proportion of individuals, overestimating and underestimating the clinical relevance of excess adiposity, and fails to significantly differentiate the increased mortality risk.” It is important to note that the study relied on previously collected medical records rather than standardised clinical assessments for all participants. Consequently, prospective studies are needed to validate and refine these criteria.
Nevertheless, specialists believe that this research supports the global applicability of the proposed classification scheme across various healthcare settings. They assert that its implementation could help mitigate organ damage and obesity-related mortality by guiding prevention, medical care, and treatment intensity according to individual patient needs.